Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taste Preference for ESL Suspension Flavours in Paediatric Epilepsy
NCT02021461Phase 2Completed
- Sponsor
- BIAL
- Start
- Dec 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of eslicarbazepine acetate in focal epilepsy (3 arms), sponsored by BIAL. Primary endpoint: Assessment of Taste Preference. Started Dec 2012; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT02021461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02021461.